Next-Generation IV Infusion Pumps Market Size, Share & Trends Analysis Report By Type (Feed grade, Nutrition grade), By Source (Natural, Synthetic), By Form (Dry, Liquid), By Application (Nutrition, Consumer, Agrochemical, Pharmaceutical, Other) Based on Region, And Segment Forecasts, 2021 - 2027

  • Report ID: BMRC 1627 | Number of pages: 198 | Published Date: Aug 2021

    Published | Category: Medical Device | Delivery Timeline: 48 hrs

COVID-19
To know the impact of COVID-19 On Next-Generation IV Infusion Pumps Market Size, Share & Trends Analysis Report By Type (Feed grade, Nutrition grade), By Source (Natural, Synthetic), By Form (Dry, Liquid), By Application (Nutrition, Consumer, Agrochemical, Pharmaceutical, Other) Based on Region, And Segment Forecasts, 2021 - 2027 Market

Request Now
Market Size Forecast Scenarios (Optimistic, Baseline and Pessimistic) 2021-2027

Global Next-Generation IV Infusion Pumps Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2021-2027- Increasing incidences of chronic diseases, growing technological developments and rising demand for ambulatory infusion pumps in homecare settings are some of the major factors anticipated to drive the growth of Global Next-Generation IV Infusion Pumps Market.

Global Next-Generation IV Infusion Pumps Market is valued at USD 1923.4 Million in 2020 and expected to reach USD 2854.1 Million by 2027 with a CAGR of 5.8% over the forecast period.

Scope of Global Next-Generation IV Infusion Pumps Market Report:

Next-Generation IV infusion pumps are designed to improve infusion efficiency and system usability, so as to reduce potential IV medication errors. These systems give patient infusion information to better informed choices in the management regarding genuine health problems. Introduction of real-time dosing direction and programmed drug library gives quick feedback on drug consistence, which helps clinicians in choosing the drug concentration from the suitable predetermined list. In addition, the presentation of this technology also diminishes manual steps, as smart infusion pump have the arrangement of auto programming and auto documentation with Electronic Medical Record (EMR) and Bar Code Medication Administration (BCMA). Presentation of Smartphone user gives programming precision and security to proficiently manage infusion pumps. Real-time display of infusion details alongside system dashboard supports clinicians with better IV infusion organization.  In 1658, the first working IV infusion device was invented by the famous English architect Christopher Wren.

COVID-19 pandemic has shown a positive impact on the growth of the global next-generation IV infusion pump market. During COVID-19 pandemic, increased demand of next-generation IV infusion pumps to treat number of Coronavirus patients across the globe has created a massive-short term flood in the demand of next-generation IV infusion pumps. Quicker regularity approvals during this time-frame will additionally propel the worldwide the market possibilities. However, in number of countries situations like lockdown has stopped manufacturing which has fundamentally contributed in the market disturbance. Thus, organizations are dealing with short term operational issues because of supply chain constraints and the inaccessibility of industrial facilities because of the COVID-19 outbreak.

The global next-generation IV infusion pumps market is segmented on the basis of product type, application end-user and region & country level. On the basis of product type, the next-generation IV infusion pumps market is divided into large volumetric infusion systems, patient controlled analgesia pumps, syringe infusion system, electronic -ambulatory infusion system, implantable infusion system, MRI compatible IV infusion pumps system, disposable elastomeric infusion system, IV disposables. On the basis of application, the market is divided into chemotherapy/oncology, diabetes, gastroenterology, analgesia/pain management, paediatrics/neonatology, hematology and other applications. On the basis of end-user, market is divided into hospitals, home care settings, ambulatory care settings and academic & research institutes.

Global Next-Generation IV Infusion Pumps Market Segmentation:

By Product

  • Large Volumetric Infusion Systems
  • Syringe Infusion Systems
  • Electronic Ambulatory Infusion Systems
  • Patient Controlled Analgesia Pumps
  • Disposable Elastomeric Infusion Systems
  • Implantable Infusion Systems
  • MRI-Compatible IV Infusion Pump Systems
  • IV Disposables

 By Application

  • Chemotherapy/Oncology
  • Diabetes
  • Gastroenterology
  • Analgesia/Pain Management
  • Pediatrics/Neonatology
  • Hematology
  • Other Applications

By End-User

  • Home Care Settings
  • Hospitals
  • Ambulatory Care Settings
  • Academic & Research Institutes

The regions covered in next-generation IV infusion pumps market report are North America, Europe, Asia-Pacific, Latin America and Rest of the World. On the basis of country level, the market of global next-generation IV infusion pumps sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, India, Japan, South East Asia, Middle East Asia (Saudi Arabia, Egypt, UAE) GCC, Africa, etc.

Key Players for Global Next-Generation IV Infusion Pumps Market Report:

Key players operating in the next-generation IV infusion pumps market include Becton, Dickinson and Company (CareFusion), Baxter International Inc., Fresenius Kabi AG, B. Braun Melsungen AG, Smiths Medical (Smiths Group plc.), ICU Medical (Hospira Inc.), iRadimed Corporation, Zyno Medical, Medtronic Plc, Terumo Corporation, Nipro Corporation, Summit Medical Products, Inc, Ambu A/S, Gamastech S.R.L, vTitan, Acromed AG , Flowonix Medical, Inc, Halyard Health, Tricumed Medizintechnik GmbH, Ivenix, Inc and others.

Next-Generation IV Infusion Pumps Market

News: Baxter Received CE Marking and Australian Regulatory Approval for Evo IQ Syringe Infusion System, Building on Smart Pump Platform

On May 20th, 2020; Baxter International Inc announced CE marking and regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for the Evo IQ Syringe Infusion System. The company expects hospitals in the United Kingdom, Ireland, Greece, Australia and New Zealand to be among the first to receive the new system, with additional countries to follow in a series of planned regulatory submissions.

Baxter Announced CE Mark and Regulatory Approval of New Evo IQ Infusion System for the United Kingdom, Ireland, Australia and New Zealand

On August 1st, 2018; Baxter International Inc. announced the CE marking of the Evo IQ Infusion System. In addition to the planned marketing of the device in the United Kingdom, Ireland and New Zealand, the Evo IQ Infusion System recently received regulatory approval by the Therapeutic Goods Administration (TGA) in Australia. These markets represent the first in a series of planned regulatory submissions for the Evo IQ Infusion System in countries around the world, with commercial launch activities starting in the third quarter of 2018.

Increasing Incidences of Chronic Diseases, Growing Technological Developments and Rising Demand for Ambulatory Infusion Pumps in Homecare Settings are Some of the Major Factors Driving the Market Growth

One of the major factors driving the growth of next-generation IV infusion pumps market is increasing incidences of chronic diseases. For instance; according to National Health Council, chronic diseases influence approximately 133 million Americans, addressing over 40% of the total population of this country. By 2020, that number is projected to rise to an expected 157 million, with 81 million having numerous conditions. In addition, rising technological advancements has also been witnessed to boost next-generation IV infusion pumps market during the forecast period. Furthermore, rising demand for ambulatory infusion pumps in homecare settings are also supplementing the market growth. For instance; as per the news published on March 9th, 2021, Eitan Medical received EU MDR clearance for Sapphire infusion system. Eitan Medical's Sapphire infusion system provides clinicians in medical clinics and home care environment across Europe to delivers an improved on work process, rising its convenience.

However, lack of skilled professionals and lack of standard guidelines for product usage are anticipated to hinder the growth of next generation IV infusion pumps market. In spite of that, government support for start-ups, approving regulatory policies, and growth in production capacity can offer more opportunities in the global next-generation IV infusion pumps market.

North America is Anticipated to Dominate the Global Next-Generation IV Infusion Pumps Market

North America is expected to dominate the global next-generation IV infusion pumps market due to growing technological advancements in healthcare infrastructure, presence of key players and collaboration of various organizations in this region. In addition, increasing cases of chronic diseases, rising geriatric population and high investment on research & development activities in this region are also supplementing the market growth. For example; as per The Rural Health Information Hub; The U.S. population is aging. Today, there are more than 46 million older adults age 65 and older living in the U.S.; by 2050, that number is expected to grow to almost 90 million.

Asia Pacific is predicted to witness the fastest development in next-generation IV infusion pumps in the coming years due to increasing prevalence of chronic diseases, advancements in the field of intravenous treatment in the region. According to CDC, India has the 6.51 crore diabetes cases which is second most highest number of diabetics in the world and is projected to have 10.9 crore influenced people by 2035. The prevalence of diabetes in the nation is 9%. It is assessed that there are another 3.5 crore undiscovered cases of diabetes in India. Non communicable diseases represent 0.98 crore deaths in the country and of all deaths 2% are because of diabetes every year.

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia
Report Analysis Details
Historical data 2015 - 2020
Forecast Period 2021 - 2027
Market Size in 2020: USD 1923.4 Million
Base year considered 2020
Forecast Period CAGR %:

5.8% 

Market Size Expected in 2027: USD 2854.1 Million
Tables, Charts & Figures: 175
Pages 198
Key Players/Companies Becton, Dickinson and Company (CareFusion), Baxter International Inc., Fresenius Kabi AG, B. Braun Melsungen AG, Smiths Medical (Smiths Group plc.), ICU Medical (Hospira Inc.), iRadimed Corporation, Zyno Medical, Medtronic Plc, Terumo Corporation, Nipro Corporation, Summit Medical Products, Inc, Ambu A/S, Gamastech S.R.L, vTitan, Acromed AG , Flowonix Medical, Inc, Halyard Health, Tricumed Medizintechnik GmbH, Ivenix, Inc and others.
Segments Covered By Product, By Application, By End-User
Regional Analysis North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

Key Benefits for Global Next-Generation IV Infusion Pumps Market Report:

  • Global Next-Generation IV Infusion Pumps Market report covers in-depth historical and forecast analysis.
  • Global Next-Generation IV Infusion Pumps Market research report provides detail information about market introduction, market summary, global market revenue (revenue USD), market drivers, market restraints, market opportunities, competitive analysis, regional and country level.
  • Global Next-Generation IV Infusion Pumps Market report helps to identify opportunities in marketplace.
  • Global Next-Generation IV Infusion Pumps Market report covers extensive analysis of emerging trends and competitive landscape.

 


Frequently Asked Questions (FAQ) :
Global Next-Generation IV Infusion Pumps Market is valued at USD 1923.4 Million in 2020 and expected to reach USD 2854.1 Million by 2027 with a CAGR of 5.8% over the forecast period.
Global Next-Generation IV Infusion Pumps Market is valued at USD 1923.4 Million in 2020 and expected to reach USD 2854.1 Million by 2027 with a CAGR of 5.8% over the forecast period.
North America is expected to dominate the global next-generation IV infusion pumps market due to growing technological advancements in healthcare infrastructure, presence of key players and collaboration of various organizations in this region.
Becton, Dickinson and Company (CareFusion), Baxter International Inc., Fresenius Kabi AG, B. Braun Melsungen AG, Smiths Medical (Smiths Group plc.), ICU Medical (Hospira Inc.), iRadimed Corporation, Zyno Medical, Medtronic Plc, Terumo Corporation, Nipro Corporation, Summit Medical Products, Inc, Ambu A/S, Gamastech S.R.L, vTitan, Acromed AG , Flowonix Medical, Inc, Halyard Health, Tricumed Medizintechnik GmbH, Ivenix, Inc and others.



Interested in this report?

Next-Generation IV Infusion Pumps Market Size, Demand & Growth Analysis 2021| Research Report

report cover

Request for Table of Content

Next-Generation IV Infusion Pumps Market Size, Share & Trends Analysis Report By Type (Feed grade, Nutrition grade), By Source (Natural, Synthetic), By Form (Dry, Liquid), By Application (Nutrition, Consumer, Agrochemical, Pharmaceutical, Other) Based on Region, And Segment Forecasts, 2021 - 2027

Note: For delivery of sample pages you must have a Domain Specific Email ID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc. are not accepted.
Brandessence market research actively tracks, monitors, and analyses key industry trends in real-time via B2B surveys in 60 + countries and territories.

    Pricing


Looking for Regional Reports?